1.
Comparative Efficacy of Tirzepatide, Teneligliptin, and Empagliflozin in HbA1c Reduction in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis. Int J Med Surg Sci [Internet]. 2023 Sep. 20 [cited 2026 Jun. 26];10(3):1-18. Available from: https://revistas.uautonoma.cl/index.php/ijmss/article/view/2263